Amarin Corp Plcuk (AMRN) Interest & Investment Income (2010 - 2026)

Amarin Corp Plcuk (AMRN) reported Interest & Investment Income of $2.4 million for Q1 2026, down 15.63% year-over-year from $2.9 million in Q1 2025, and down 5.94% quarter-over-quarter from $2.6 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Interest & Investment Income (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 17 years of Interest & Investment Income data on file, last reported at $2.4 million in Q1 2026.

  • Interest & Investment Income for Q1 2026 came in at $2.4 million, down 15.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.4 million (down 19.31% YoY), and the FY2025 annual result was $10.9 million, down 19.03% from the prior year.
  • Interest & Investment Income eased to $2.4 million in Q1 2026 per AMRN's latest filing, from $2.6 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $3.4 million in Q4 2023 and troughed at $203000.0 in Q1 2022.
  • A 5-year average of $2.4 million and a median of $2.8 million in 2025 frame the typical range for Interest & Investment Income.
  • The sharpest annual moves came in 2022 and 2023: Interest & Investment Income plunged 56.9% in 2022, then soared 994.09% in 2023.
  • A 5-year view of Interest & Investment Income shows it stood at $1.6 million in 2022, then jumped by 117.05% to $3.4 million in 2023, then retreated by 1.46% to $3.4 million in 2024, then dropped by 23.67% to $2.6 million in 2025, then declined by 5.94% to $2.4 million in 2026.
  • Business Quant data shows AMRN's Interest & Investment Income at $2.4 million in Q1 2026, $2.6 million in Q4 2025, and $2.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 29.66 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 229.00 Mn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -645.00 Mn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn -
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn 2.42 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.42 Mn
Dec 31, 2025 2.58 Mn
Sep 30, 2025 2.78 Mn
Jun 30, 2025 2.62 Mn
Mar 31, 2025 2.87 Mn
Dec 31, 2024 3.38 Mn
Sep 30, 2024 3.37 Mn
Jun 30, 2024 3.27 Mn
Mar 31, 2024 3.38 Mn
Dec 31, 2023 3.43 Mn
Sep 30, 2023 3.22 Mn
Jun 30, 2023 3.00 Mn
Mar 31, 2023 2.22 Mn
Dec 31, 2022 1.58 Mn
Sep 30, 2022 750,000.00
Jun 30, 2022 288,000.00
Mar 31, 2022 203,000.00
Dec 31, 2021 301,000.00
Sep 30, 2021 163,000.00
Jun 30, 2021 285,000.00